-- Health care stocks rose late Tuesday afternoon, with the NYSE Health Care Index and the State Street Health Care Select Sector SPDR ETF (XLV) each increasing 0.4%.
The iShares Biotechnology ETF (IBB) was shedding 0.2%.
In corporate news, Edgewise Therapeutics (EWTX) shares jumped 22% after Wedbush lifted the company's price target to $46 from $32, while keeping its outperform rating.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Corteva delivered strong Q1 2026 results with operating EPS of $1.50 significantly exceeding consensus view of $1.18 (+33% Y/Y) and net sales of $4.9B (+11% Y/Y), $270M above expectations. Organic sales growth of 7% Y/Y reflected broad-based demand for differentiated technology offerings despite challenging agricultural conditions. The robust execution demonstrates management's ability to execute the separation strategy from a position of strength, with 6% global volume gains showcasing continued farmer adoption of advanced solutions. Management maintained the 2026 guidance with operating EBITDA of $4.0B-$4.2B and operating EPS of $3.45-$3.70, targeting Q4 2026 for separation completion. The Seed segment delivered exceptional performance with 34.2% operating EBITDA margins (+310 bps Y/Y), while Crop Protection maintained solid momentum with 23.1% margins (+101 bps Y/Y), reinforcing our view that both segments are well positioned for the planned separation with milestones progressing as expected.